Evidence map›Paper›PMID 29536280›Full record

ArticleJournal of medical ultrasonics (2001)2018

A novel ultrasonic method for evaluation of blood clotting parameters.

Vacis Tatarunas, Algirdas Voleisis, Reimondas Sliteris, Rymantas Kazys, Liudas Mazeika, Vaiva Lesauskaite

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of medical ultrasonics (2001), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vacis TatarunasLaboratory of Molecular Cardiology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukileliu 15, 50009, Kaunas, Lithuania. vacis.tatarunas@lsmuni.lt.ORCID http://orcid.org/0000-0002-2389-1550
Algirdas VoleisisUltrasound Institute, Kaunas University of Technology, K. Baršausko g. 59, Kaunas, Lithuania.
Reimondas SliterisUltrasound Institute, Kaunas University of Technology, K. Baršausko g. 59, Kaunas, Lithuania.
Rymantas KazysUltrasound Institute, Kaunas University of Technology, K. Baršausko g. 59, Kaunas, Lithuania.
Liudas MazeikaUltrasound Institute, Kaunas University of Technology, K. Baršausko g. 59, Kaunas, Lithuania.
Vaiva LesauskaiteLaboratory of Molecular Cardiology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukileliu 15, 50009, Kaunas, Lithuania.

Funding

Kaunas University of Technology UKOAGKaunas University of Technology UKOAGIILithuanian University of Health Sciences UKOAGLithuanian University of Health Sciences UKOAGII
6 · The paper itself

Abstract

purposeFor long time, blood clot retraction was measured only by thromboelastographic or platelet contractile force measurement techniques. The purpose of the present study was development of a novel ultrasonic method based on simultaneous monitoring of variations in the ultrasound velocity and the frequency spectrum of the signal propagating in clotting blood and its application for automatic evaluation of blood clotting parameters.

methodsSimultaneous measurement of ultrasound velocity and variations in the frequency spectrum of wideband ultrasonic signals in clotting blood samples was performed. All measurements were performed in pulse-echo mode. Standard clinical data were obtained using routine clinical laboratory methods.

resultsThe amplitudes of ultrasonic signals during native blood coagulation varied up to ten times for different frequencies. The measurement results of the start and duration of blood clot retraction differed between patient samples: different components of the blood coagulation system had significant impact on the blood clot retraction process.

conclusionsOur results showed that during blood clotting, the ultrasound velocity and variations in frequency spectrum should be used simultaneously to determine the beginning and duration of blood clot retraction. Our results also showed that blood clot retraction is controlled by the activity of factor XIII.

Indexed as

Blood CoagulationAdultBlood Coagulation TestsEquipment DesignFemaleHumansMaleUltrasonic WavesUltrasonographyBlood clot retractionFactor XIIIFrequency spectrumUltrasoundUltrasound velocity

Identifiers

PMID29536280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.